Selected Titles

The latest videos and pictures

4R4A2655-Pano

Introduction of Actoverco Cardiovascular Medications at the 8th International Heart Failure Congress

IMGM0506

Visual Report on the Introduction of “gynati” and “prequin”

actonib launch

Visual Report on the Introduction of Actonib and Its application in Dermatology

HY6A3173

Neurostyle Launch Event

nahaleh naraghi

Interview with Nahaleh Naraqi about Actoverco social responsibilities

The latest news and articles

Nahaleh Naraghi irán pharma
No Comments

Actoverco received 90.8 million Euros of governmental currency in the first half of this year

The CEO of Actoverco said: “This Company has received about 90 million and 800 thousand Euros of governmental currency in the first 6 months of the year.”

No Comments

We do not talk, we act

Shini, CEO of Actoverco on the sidelines of ICCU 2018 in a conversation with PHANA: With proper planning, none of the Actoverco’s drugs will not experience a shortage. We have…

nahaleh naraghi ceo of actoverco
No Comments

With the lifting of sanctions, many announced their readiness to work with “Actoverco

We have a program for production of Rituximab and Bevacizumab drugs for cancer patients, ophthalmologists, etc. These drugs are very expensive due to their high technical knowledge, and from next year, we will also produce the raw materials for these drugs ourselves.

Conferences and Exhibitions

MIL14860

Congress

__HA0325

2021 Pharmax Middle East Festival

2021 Pharmax Middle East Festival will be held from 19 to 21 October 2021 in Hall 5 (Nations)...
__HA0603

6th exhibition of Iran Pharma (IPH) opening ceremony

The opening ceremony of the 6th Iran Pharma Exhibition, the largest international specialized gathering of the country's pharmaceutical...
MIL14688

Introduction of new drugs